已收录 268921 条政策
 政策提纲
  • 暂无提纲
Insulin and adipokine signaling and their cross-regulation in postmortem human brain
[摘要] Aberrant insulin and adipokine signaling has been implicated in cognitive decline associated with both type 2 diabetes mellitus and neurodegenerative diseases. We established methods that reliably measure insulin, adiponectin and leptin signaling, and their crosstalk, in thawed postmortem mid-frontal cortical tissue from cognitively normal older subjects with a short postmortem interval. Insulin-evoked insulin receptor (IR) activation increases activated, tyrosine-phosphorylated IR beta on tyrosine residues 960, 1150, and 1151, insulin receptor substrate-1 recruitment to IR beta and phosphorylated RAC-alpha-serine/threonineprotein kinase. Adiponectin augments, but leptin inhibits, insulin signaling. Adiponectin activates adiponectin receptors to induce APPL1 binding to adiponectin receptor 1 and 2 and T-cadherin and downstream adenosine monophosphate-dependent protein kinase phosphorylation. Insulin inhibited adiponectin-induced signaling. In addition, leptin-induced leptin receptor (OB-R) signaling promotes Janus kinase 2 recruitment to OB-R and Janus kinase 2 and downstream signal transducer and activator of transcription 3 phosphorylation. Insulin enhanced leptin signaling. These data demonstrate insulin and adipokine signaling interactions in human brain. Future studies can use these methods to examine insulin, adiponectin, and leptin metabolic dysregulation in aging and disease states, such as type 2 diabetes and Alzheimer's disease-related dementias. (C) 2019 Elsevier Inc. All rights reserved.
[发布日期] 2019-12-01 [发布机构] 
[效力级别]  [学科分类] 
[关键词] insulin signaling;Adipokine;Adiponectin receptors;Leptin receptors;Postmortem brain;Type 2 diabetes;Alzheimer's disease-related dementias [时效性] 
   浏览次数:1      统一登录查看全文      激活码登录查看全文